Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2015 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. Look for comparisons against own past, already real and recurring, early stage. Transcript: Matt Rizai discusses growth, non-SEC use cases, expansion. Stuart Miller discusses revenue, retention rates, add-on revenue retention rate increased. He says "increase subscription bookings from existing customers on non-SEC use cases with the primary driver of the inquiries in the add-on revenue retention rate." That suggests existing customers are buying more, but not necessarily that each new deal is larger. No explicit statement about average deal size increasing, new customers starting at higher scope, etc. There is mention of "average contract value on subscription and support from all customers continued to rise." That is a metric that could indicate larger deals, but it's not specifically about new engagements being larger. It could be from price increases or add-ons. But the question asks about successive engagements of the same kind coming in at progressively larger size. The transcript does not explicitly say that new deals are larger than before. It mentions expansion into new use cases, but that's about breadth of offerings, not necessarily unit size of same offering. No mention of record deals or upward drift in deal size. No comparison of current deals to past deals in terms of size. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.